Aug 12, 2025 8:00am EDT ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
Aug 11, 2025 8:00am EDT ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025